Treatment of primary intraocular lymphoma with oral trofosfamide: Report of two cases and review of the literature

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 242, Issue 9, 2004, Pages 771-776

  Jahnke, Kristoph ^a   Bechrakis, Nikolaos E ^a   Coupland, Sarah E ^a   Schmittel, Alexander ^a   Foerster, Michael H ^a   Fischer, Lars ^a   Thiel, Eckhard ^a   Korfel, Agnieszka ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARMUSTINE; CYTARABINE; DEXAMETHASONE; HEMOGLOBIN; METHOTREXATE; PROCARBAZINE; TOPOTECAN; TROFOSFAMIDE;

ADULT; AGED; ANEMIA; ARTICLE; BRAIN RADIATION; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CASE REPORT; DRUG DOSE REGIMEN; DRUG MEGADOSE; DRUG WITHDRAWAL; EYE CANCER; FEMALE; HUMAN; HUMAN TISSUE; LARGE CELL LYMPHOMA; LYMPHOCYTIC INFILTRATION; LYMPHOMA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OPHTHALMOSCOPY; PAPILLEDEMA; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; PRIMARY INTRAOCULAR LYMPHOMA; PRIORITY JOURNAL; RETINA MACULA EDEMA; VISUAL ACUITY; VISUAL IMPAIRMENT; VITRECTOMY;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; CHOROID NEOPLASMS; CYCLOPHOSPHAMIDE; FEMALE; HUMANS; LYMPHOMA, B-CELL; MALE; MIDDLE AGED; TUMOR MARKERS, BIOLOGICAL;

EID: 6344239187     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-004-0947-2     Document Type: Article

References (32)

1. Andersson PO, Braide I, Nilsson-Ehle H (2002) Trofosfamide as salvage therapy for anaplastic large cell lymphoma relapsing after high-dose chemotherapy. Leuk Lymphoma 43:2351-2353
2. Batchelor TT, Kolak G, Ciordia R, Foster CS, Henson JW (2003) High-dose methotrexate for intraocular lymphoma. Clin Cancer Res 9:711-715
3. Baumann MA, Ritch PS, Hande KR, Williams GA, Topping TM, Anderson T (1986) Treatment of intraocular lymphoma with high-dose Ara-C. Cancer 57:1273-1275
4. Bechrakis NE, Foerster MH, Bornfeld N (2002) Biopsy in indeterminate intraocular tumors. Ophthalmology 109:235-242
5. Buggage RR, Chan CC, Nussenblatt RB (2001) Ocular manifestations of central nervous system lymphoma. Curr Opin Oncol 13:137-142
6. Cassoux N, Merle-Beral H, Leblond V, Bodaghi B, Milea D, Gerber S, Fardeau C, Reux I, Xuan KH, Chan CC, LeHoang P (2000) Ocular and central nervous system lymphoma: clinical features and diagnosis. Ocul Immunol Inflamm 8:243-250
7. Char DH, Ljung BM, Miller T, Phillips T (1988) Primary intraocular lymphoma (ocular reticulum cell sarcoma) diagnosis and management. Ophthalmology 95:625-630
8. Char DH, Ljung BM, Deschenes J, Miller TR (1988) Intraocular lymphoma: immunological and cytological analysis. Br J Ophthalmol 72:905-911
9. Cordell JL, Falini B, Erber WN, Ghosh AK, Abdulaziz Z, MacDonald S, Pulford KA, Stein H, Mason DY (1984) Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 32:219-229
10. Coupland SE, Bechrakis NE, Anastassiou G, Foerster AM, Heiligenhaus A, Pleyer U, Hummel M, Stein H (2003) Evaluation of vitrectomy specimens and chorioretinal biopsies in the diagnosis of primary intraocular lymphoma in patients with Masquerade syndrome. Graefes Arch Clin Exp Ophthalmol 241:860-870
11. Drings P, Allner R, Brock N, Burkert H, Fischer M, Folsch E, Gerhartz H, Gotzky P, Hoppe I, Kanzler G, Klein HO, Mainzer K, Martin H, Obrecht P, Palme G, Paulisch H, Riegg H, Schubert JC, Treske U, Weise W, Willems D, Wilmanns H, Witte S, Wohlenberg H (1970) Erfahrungen mit neuartigen N-Lost-Phosphoramiden. Dtsch Med Wochenschr 95:491-497
12. Eby NL, Grufferman S, Flannelly CM, Schold SC Jr, Vogel FS, Burger PC (1988) Increasing incidence of primary brain lymphoma in the US. Cancer 62:2641-2665
13. Ferreri AJ, Blay JY, Reni M, Pasini F, Gubkin A, Tirelli U, Calderoni A, Zucca E, Cortelazzo S, Chassagne C, Tinguel M, Borisch B, Berger F, Ponzoni M, Cavalli F, International Extranodal Lymphoma Study Group (IELSG) (2002) Relevance of intraocular involvement in the management of primary central nervous system lymphomas. Ann Oncol 13:531-538
14. Fine HA, Mayer RJ (1993) Primary central nervous system lymphoma. Ann Intern Med 119:1093-1104
15. Freilich RJ, Delattre JY, Monjour A, DeAngelis LM (1996) Chemotherapy without radiation therapy as initial treatment for primary CNS lymphoma in older patients. Neurology 46:435-439
16. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC (1994) A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84:1361-1392
17. Helsing MD (1997) Trofosfamide as a salvage treatment with low toxicity in malignant lymphoma. A phase II study. Eur J Cancer 33:500-502
18. Hsu SM, Raine L, Fanger H (1981) Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29:577-580
19. Mason JO, Fischer DH (2003) Intrathecal chemotherapy for recurrent central nervous system lymphoma. Ophthalmology 110:1241-1244
20. Reichardt P, Pink D, Tilgner J, Kretzschmar A, Thuss-Patience PC, Dörken B (2002) Oral trofosfamide: an active and well-tolerated maintenance therapy for adult patients with advanced bone and soft tissue sarcomas. Results of a retrospective analysis. Onkologie 25:541-546
21. Reni M, Ferreri AJ, Villa E (1999) Second-line treatment for primary central nervous system lymphoma. Br J Cancer 79:530-534
22. Rothova A, Ooijman F, Kerkhoff F, Van Der Lelij A, Lokhorst HM (2001) Uveitis masquerade syndromes. Ophthalmology 108:386-399
23. Salminen E, Nikkanen V, Lindholm L (1995) Trofosfamide is effective in refractory non-Hodgkin's lymphoma. Eur J Cancer 31A:2419-2420
24. Sandor V, Stark-Vancs V, Pearson D, Nussenblat R, Whitcup SM, Brouwers P, Parronas N, Heiss J, Jaffe E, deSmet M, Kohler D, Simon R, Wittes R (1998) Phase II trial of chemotherapy alone for primary CNS and intraocular lymphoma. J Clin Oncol 16:3000-3006
25. Schlegel U, Pels H, Glasmacher A, Kleinschmidt R, Schmidt-Wolf I, Helmstaedter C, Fliessbach K, Deckert M, Van Roost D, Fimmers R, Bode U, Klockgether T (2001) Combined systemic and intraventricular chemotherapy in primary CNS lymphoma: a pilot study. J Neurol Neurosurg Psychiatry 71:118-122
26. Smith JR, Rosenbaum JT, Wilson DJ, Doolittle ND, Siegal T, Neuwelt EA, Pe'er J (2002) Role of intravitreal methotrexate in the management of primary central nervous system lymphoma with ocular involvement. Ophthalmology 109:1709-1716
27. Soussain C, Suzan F, Hoang-Xuan K, Cassoux N, Levy V, Azar N, Belanger C, Achour E, Ribrag V, Gerber S, Delattre JY, Leblond V (2001) Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma. J Clin Oncol 19:742-749
28. Strauchen JA, Dalton J, Friedman AH (1989) Chemotherapy in the management of intraocular lymphoma. Cancer 63:1918-1921
29. Wagner A, Hempel G, Boos J (1997) Trofosfamide: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the oral treatment of cancer. Anticancer Drugs 8:419-431
30. Whitcup SM, de Smet MD, Rubin BI, Palestine AG, Martin DF, Burnier M Jr, Chan CC, Nussenblatt RB (1993) Intraocular lymphoma. Clinical and histopathologic diagnosis. Ophthalmology 100:1399-1406
31. Wist E, Risberg T (1991) Trofosfamide in non-Hodgkin's lymphoma. A phase II study. Acta Oncol 30:819-821
32. Yule SM, Price L, Pearson AD, Boddy AV (1997) Cyclophosphamide and ifosfamide metabolites in the cerebrospinal fluid of children. Clin Cancer Res 3:1985-1992